Found 0 matching trials
Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A PHASE1 Sobi.BIVV001-003 is an open-label, 2-period, fixed sequence study for intra...
Show More Location
Sobi Investigational Site
Learn More & Join Trial
Impact on French Physician's Haemophilia Treatment Management Decision Based on Systematic Joint Examination NA This low interventional study aims to describe if and how the haemophilia t...
Show More Location
Swedish Orphan Biovitrum Research site
Learn More & Join Trial
Study of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia A PHASE1 The study is to investigate the safety, tolerability, and pharmacokinetics ...
Show More Learn More & Join Trial
A Gene Transfer Study for Hemophilia A PHASE1 This clinical research study is being conducted by Spark Therapeutics, Inc....
Show More Location
University of California Davis - Hemostasis and Thrombosis Center
Learn More & Join Trial
Clot Formation and Clot Stability in Patients With Severe Haemophilia A NA In the present study we are examining the clot formation and clot stability...
Show More Location
Department of Clinical Biochemistry, Center for Haemophilia and Thrombosis
Learn More & Join Trial
Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015 PHASE3 This trial is conducted in Asia, Europe, Japan, Oceania, North America and ...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Type 3 Von Willebrand International Registries Inhibitor Prospective Study N/A International Registries and Prospective Study on Type 3 Von Willebrand's D...
Show More Location
Helsinki University Central Hospital, Department Internal Medicine, Coagulation Disorders, at Haematology and Laboratory Services
Learn More & Join Trial
Treatment of Hemophilia A Patients With FVIII Inhibitors N/A This is a non-interventional, multicenter, observational, international stu...
Show More Location
Arthur M. Blank Hospital
Learn More & Join Trial
Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine Prophylaxis N/A This NIS aims to assess the patient-reported outcomes (PROs) in enrolled su...
Show More Location
Multiple Locations
Learn More & Join Trial
An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A PHASE2 This is an open-label, non-randomized, efficacy, safety and pharmacokinetic...
Show More Learn More & Join Trial